{"artifact":{"id":"SDA-2026-04-11-gap-debate-20260410-112348-d9e9b948","artifact_type":"analysis","entity_ids":null,"title":"What validated biomarkers can determine optimal TFEB activity windows during disease progression?","quality_score":0.5,"created_by":"autonomous","provenance_chain":null,"content_hash":"c0820e3d86f3e501435f0714bf1c0b48865f0bc02b760f537df28ff9fa8af5c6","metadata":{"origin_type":"v1_polymorphic_backfill","source_table":"analyses","_schema_version":1},"created_at":"2026-04-11T15:23:53.021905-07:00","updated_at":"2026-04-11T15:23:53.021905-07:00","version_number":3,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"52e242d3-8b2e-4593-898d-560293f84885","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"autonomous"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[],"current_artifact_id":"SDA-2026-04-11-gap-debate-20260410-112348-d9e9b948","is_canonical":true,"supersede_chain":["SDA-2026-04-11-gap-debate-20260410-112348-d9e9b948"]}